M1163 HCPCS Reimbursement & Policy Benchmarks | OpenPayer

Summary & Overview

HCPCS Level II M1163: Anaphylaxis Due to HPV Vaccine Before Age 13

HCPCS Level II code M1163 documents an instance of anaphylaxis attributed to the human papillomavirus (HPV) vaccine occurring on or before a patient's 13th birthday. This code captures a specific vaccine-related adverse event important for patient safety reporting, clinical follow-up, and payer adjudication. Nationally, accurate capture of vaccine-related anaphylaxis supports public health surveillance and informs immunization safety monitoring.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for M1163, the typical sites of service where the event is managed, and what to expect in billing and documentation workflows. The publication summarizes benchmarking considerations, common modifiers listed in the input, and where this code fits within immunization and adverse event reporting processes.

The content is intended for a national audience and addresses clinical relevance, administrative capture, and coding context rather than payer-specific reimbursement policies. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareM1163HCPCS Level IIHPV vaccineanaphylaxisvaccine adverse eventimmunization safetyoutpatientemergency departmentclinical documentation

Billing Code Overview

HCPCS Level II code M1163 indicates a patient who experienced anaphylaxis due to the HPV vaccine at any time on or before the patient's 13th birthday. The service type is vaccine adverse event documentation / immunization reaction. The typical site of service for this code is outpatient clinic or emergency department, where the adverse event is evaluated and documented.

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 12-year-old female receives a routine human papillomavirus (HPV) vaccination in a pediatric clinic. Within minutes to hours after administration she develops signs of anaphylaxis: generalized urticaria, facial swelling, respiratory distress with wheeze, hypotension, and syncope. Nursing initiates emergency protocols, calls the physician, and documents time of vaccine, onset of symptoms, vital signs, and treatments administered. The clinician administers intramuscular epinephrine, provides airway support and supplemental oxygen, establishes intravenous access, and orders adjunctive medications (antihistamine, corticosteroid, bronchodilator) as indicated. The patient is monitored in a monitored recovery area or transferred to the emergency department if symptoms are severe or persistent. Documentation includes the offending vaccine lot number, site of administration, exact timing of symptom onset, treatments with doses and routes, informed consent discussions with the parent/guardian, and discharge instructions or transfer notes. Billing uses the HCPCS Level II code M1163 to indicate anaphylaxis due to the HPV vaccine occurring on or before the patient’s 13th birthday; associated facility and professional claims include procedure and emergency service codes as appropriate.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work or complexity for emergency management (documentation, extended time) is substantially greater than typical.

HCPCS M1392: Documentation of No Examination (Refusal or Lost to Follow-up)

HCPCS-M1243-PATIENT-FELT-HEARD-UNDERSTOOD

HCPCS Level II M1243: Patient-Reported Feeling Heard and Understood

HCPCS-M1257-CVD-RISK-ASSESSMENT-NOT-PERFORMED-OR-INCOMPLETE

HCPCS Level II M1257: CVD Risk Assessment Not Performed or Incomplete

HCPCS-M1462-HEAD-IMAGING-CLINICAL-INDICATIONS

HCPCS M1462: Head Imaging for Clinical Indications

HCPCS-M1201-MEDICAL-REASON-NO-ACEI-OR-ARB

HCPCS M1201: Documentation of Medical Reason for Not Prescribing ACE-i/ARB Therapy

HCPCS-M1212-GLYCEMIC-STATUS-ASSESSMENT-MISSING

HCPCS M1212: Glycemic Status Assessment Missing

HCPCS-M1273-SNF-ADMISSION-WITHIN-ONE-YEAR-OF-DIALYSIS-INITIATION

HCPCS Level II M1273: SNF Admission Within One Year of Dialysis Initiation

HCPCS-M1323-POST-INJECTION-IOP-SCREENING-PLAN-OF-CARE

HCPCS M1323: Post-Injection IOP Screening and Plan of Care

HCPCS-M1211-MOST-RECENT-HBA1C-GMI-OVER-9-0

HCPCS Level II M1211: Most Recent Glycemic Status Assessment >9.0%

HCPCS-M1175-DOCUMENTATION-ZOSTER-VACCINE-CONTRAINDICATION

HCPCS Level II M1175: Documentation of Medical Reason for Not Administering Zoster Vaccine

Showing 1–10 of 356

Taxonomy Code	Specialty	Notes
`207P00000X`	Pediatric Medicine	Most common specialty managing vaccine administration and immediate anaphylaxis in children.
`207L00000X`	Allergy & Immunology	Specialists who diagnose vaccine-related anaphylaxis and advise on future immunization strategies.
`208000000X`	Emergency Medicine	Manages acute resuscitation, airway, and transfer decisions for severe anaphylaxis.
`163W00000X`	Nursing (RN)	Provides triage, urgent treatment, medication administration, and monitoring during acute event.
`2086S0205X`	Medical Toxicology	Consulted in severe or unusual reactions for management and disposition recommendations.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`T78.2XXA`	Anaphylactic shock, unspecified, initial encounter	General anaphylaxis code used when the specific trigger is not otherwise coded; applicable when documenting initial acute management.
`T78.2XXD`	Anaphylactic shock, unspecified, subsequent encounter	Use for follow-up encounters related to anaphylactic event care.
`T80.52XA`	Anaphylactic reaction due to vaccination, initial encounter	Specific code for anaphylaxis caused by a vaccine; clinically relevant to document HPV vaccine reaction.
`T88.1XXA`	Other complications following immunization, initial encounter	Captures other immediate complications following vaccination when anaphylaxis or specific reaction terms are used.
`R50.9`	Fever, unspecified	May be used if fever accompanies post-vaccination reaction and requires separate documentation.
`Z23`	Encounter for immunization	Use on encounters documenting vaccine administration history and counseling for future immunizations.
`Z91.010`	Allergy to peanuts	Example of an allergy history code; allergy history codes document prior atopic risk that may influence vaccine decision-making.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used to report intramuscular epinephrine administration for anaphylaxis treatment in outpatient settings.
`31500`	Intubation, endotracheal, emergency procedure	Performed when airway protection is required due to respiratory compromise from anaphylaxis.
`94640`	Pressurized or non-pressurized inhalation treatment for acute airway obstruction (e.g., nebulized bronchodilator)	Used when bronchodilator nebulization is required for bronchospasm during anaphylactic reaction.
`99285`	Emergency department visit, high severity	Used for high-complexity emergency department evaluation and management of severe anaphylaxis.
`36415`	Collection of venous blood by venipuncture	Performed for laboratory testing (e.g., serum tryptase, CBC, electrolytes) during or after anaphylactic event.
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Used when cardiac monitoring and ECG evaluation are performed because of hypotension, syncope, or arrhythmia risk.

OpenPayer